https://www.selleckchem.com/products/cx-5461.html
0001) and TcPO of 15% at the midfoot (35 of 41 [85.37%] vs 17 of 40 [42.50%]; P= .0001] and lower foot (37 of 41 [90.24%] vs 19 of 40 [47.50%]; P .0001). No patients with CLI underwent major amputation in group B, compared with 4 in group A (P= .039. No significant difference was observed in relief from rest pain or 30% reduction in ulcer size among patients with CLI or in 50% improvement in pain-free walking distance among patients with severe claudication. Intraarterial delivery of autologous BMSCs is safe and ef
Like
Comment
Share
